Skip to content

Assessment of the effect of improving the enteral environment by foods believed to potentially have such an effect

Assessment of the effect of improving the enteral environment by foods believed to potentially have such an effect - Enteral environment improvement effect of foods believed to have such an effect

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031641
Enrollment
100
Registered
2018-03-12
Start date
2018-03-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Subjects consume two pieces of food believed to improve the enteral environment daily for 12 weeks. Subjects consume two pieces of a placebo food daily for 12 weeks.

Sponsors

Kochi University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Those who receive an appropriate explanation of the purpose and content of the study, are able to consent, voluntarily request to participate after gaining a full understanding, and are able to consent to participation in this survey in writing. 2. Healthy individuals with a defecation frequency of 2 to 5 times per week, inclusive.

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following conditions will not be selected as study subjects: 1. Pregnant and nursing mothers, and individuals with a desire to become pregnant during the study period 2. Individuals taking medication on a routine basis 3. Individuals who are taking foods for specific health use, foods with function claims, and/or health foods, in the case that such foods affect gastrointestinal function 4. Individuals with persistent diarrhea. 5. Individuals with a fruit allergy 6. Individuals whose fasting blood test results during a physical examination include: blood glucose >=126 mg/dL, LDL cholesterol >=140 mg/dL, triglycerides >=150 mg/dL, or HDL cholesterol <40 mg/dL 7. Other individuals deemed unsuitable by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Defecation frequency, defecation quantity, stool form, stool hardness, stool color, stool odor, and post-defecation feeling

Secondary

MeasureTime frame
1. Fecal flora (Lactobacillus, Bifidobacterium) 2. Anti-metabolic syndrome effect (LDL cholesterol, triglycerides, HDL cholesterol, fasting blood sugar, insulin, HbA1c)

Countries

Japan

Contacts

Public ContactShunji Mizobuchi

Kochi Medical School, Kochi University Clinical nursing

mizoshun@kochi-u.ac.jp088-880-2564

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026